# A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect

Study · id `cardio:ct-nct02361008` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02361008](<https://clinicaltrials.gov/study/NCT02361008>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02361008

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 20121212 participants.

## Technical summary

Registry record NCT02361008. Randomized; single masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 20121212 participants (enrolled count; ClinicalTrials.gov record NCT02361008, source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT02361008, source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)
- Primary completion: 2014-12 (actual) (ClinicalTrials.gov record NCT02361008, source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)
- Completion: 2014-12 (actual) (ClinicalTrials.gov record NCT02361008, source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02361008, source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02361008-2015-02-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect
- Condition: Heart Septal Defects, Ventricular
- Condition: Double Outlet Right Ventricle, Noncommitted VSD
- Condition: Double Outlet Right Ventricle, Subaortic VSD
- Condition: Double Outlet Right Ventricle, Subpulmonary VSD
- Condition: Supracristal Ventricular Septal Defect
- Intervention (Device): TEE-guided perventricular device closure without CBP
- Intervention (Procedure): Surgery repair with CBP
- Lead sponsor: Bentong Yu
- Lead sponsor class: OTHER
- Collaborator: The Third Affiliated Hospital of Nanchang University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: 65168e02240e5c7c0e4249da8f88ca11645ab8a9d5aa611418aa5edd6a2f1d8d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
